Insulet 8-K: Officer Changes, Compensation, Reg FD Disclosure

TL;DR

**Insulet just announced executive changes and compensation details, watch for strategic shifts.**

AI Summary

Insulet Corporation filed an 8-K on January 18, 2024, to report on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for officers. This filing also includes Regulation FD Disclosure and Financial Statements and Exhibits. This matters to investors because changes in leadership and executive compensation can signal shifts in company strategy, financial health, or future performance, potentially impacting stock valuation.

Why It Matters

Changes in executive leadership and compensation can directly influence a company's strategic direction and operational efficiency, which are key drivers of stock performance.

Risk Assessment

Risk Level: medium — Changes in leadership can introduce uncertainty regarding future company direction and performance, warranting a medium risk assessment.

Analyst Insight

Investors should monitor subsequent filings or company announcements for specific details regarding the executive changes and compensation arrangements, as these will provide more actionable insights into Insulet's future direction.

Key Players & Entities

• INSULET CORPORATION (company) — Registrant as Specified in Charter
• January 18, 2024 (date) — Date of earliest event reported
• 001-33462 (other) — Commission File Number
• 04-3523891 (other) — IRS Employer Identification No.
• 100 Nagog Park Acton Massachusetts 01720 (other) — Address of Principal Executive Offices
• (978) 600-7000 (other) — Registrant’s telephone number

FAQ

From the Filing

0001145197-24-000004.txt : 20240118 0001145197-24-000004.hdr.sgml : 20240118 20240118160248 ACCESSION NUMBER: 0001145197-24-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240118 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 24541773 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20240118.htm 8-K podd-20240118 0001145197 FALSE 0001145197 2024-01-18 2024-01-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  January 18, 2024   INSULET CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-33462 04-3523891 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter) Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 18, 2024, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Flavia Pease and Tim Stonesifer as Class II and Class I directors, respectively, effective January 18, 2024. Ms. Pease will stand for election by stockholders at the Company’s 2024 Annual Meeting of Stockholders, and Mr. Stonesifer will stand for election by stockholders at the Company’s 2026 Annual Meeting of Stockholders. Ms. Pease and Mr. Stonesifer have both been named to the Audit Committee of the Board, effective March 1, 2024. Ms. Pe